Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kern

Showing results (521-530 of 555) with videos related to

Pageof 56
Sort By:
Schizophrenia Bulletin|February 25, 2011
Social cognition in schizophrenia, Part 1: performance across phase of illnessMichael F Green, Carrie E Bearden, Tyrone D Cannon, et al.
Regulatory Toxicology and Pharmacology : RTP|April 21, 2022
Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA dataSebastian Hoffmann, Nathalie Alépée, Nicola Gilmour, et al.
The British Journal of Dermatology|January 24, 2023
CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativaCristina Gamell, Aleksandra Bankovacki, Karen Scalzo-Inguanti, et al.
Pediatric Dermatology|May 28, 2026
Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis BullosaEli Sprecher, Mauricio Torres-Pradilla, Maria Florencia Fernandez, et al.
Neurology|August 25, 2017
Utilization of rehabilitation therapy services in Parkinson disease in the United StatesMichelle E Fullard, Dylan P Thibault, Andrew Hill, et al.
Biological Psychiatry|September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteriaMichael F Green, Keith H Nuechterlein, James M Gold, et al.
Journal of Parkinson'S Disease|February 27, 2018
Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation CarriersLieneke van den Heuvel, Andrew S Lim, Naomi P Visanji, et al.
Schizophrenia Bulletin|November 7, 2017
Episodic Memory for Dynamic Social Interaction Across Phase of Illness in SchizophreniaJunghee Lee, Keith H Nuechterlein, Barbara J Knowlton, et al.
Critical Reviews in Toxicology|February 24, 2018
Non-animal methods to predict skin sensitization (II): an assessment of defined approaches <sup>*</sup>Nicole C Kleinstreuer, Sebastian Hoffmann, Nathalie Alépée, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
Pageof 56

Showing results (521-530 of 555) with videos related to

Sort By:
Pageof 56
Schizophrenia Bulletin|February 25, 2011
Social cognition in schizophrenia, Part 1: performance across phase of illnessMichael F Green, Carrie E Bearden, Tyrone D Cannon, et al.
Regulatory Toxicology and Pharmacology : RTP|April 21, 2022
Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA dataSebastian Hoffmann, Nathalie Alépée, Nicola Gilmour, et al.
The British Journal of Dermatology|January 24, 2023
CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativaCristina Gamell, Aleksandra Bankovacki, Karen Scalzo-Inguanti, et al.
Pediatric Dermatology|May 28, 2026
Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis BullosaEli Sprecher, Mauricio Torres-Pradilla, Maria Florencia Fernandez, et al.
Neurology|August 25, 2017
Utilization of rehabilitation therapy services in Parkinson disease in the United StatesMichelle E Fullard, Dylan P Thibault, Andrew Hill, et al.
Biological Psychiatry|September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteriaMichael F Green, Keith H Nuechterlein, James M Gold, et al.
Journal of Parkinson'S Disease|February 27, 2018
Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation CarriersLieneke van den Heuvel, Andrew S Lim, Naomi P Visanji, et al.
Schizophrenia Bulletin|November 7, 2017
Episodic Memory for Dynamic Social Interaction Across Phase of Illness in SchizophreniaJunghee Lee, Keith H Nuechterlein, Barbara J Knowlton, et al.
Critical Reviews in Toxicology|February 24, 2018
Non-animal methods to predict skin sensitization (II): an assessment of defined approaches <sup>*</sup>Nicole C Kleinstreuer, Sebastian Hoffmann, Nathalie Alépée, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
Pageof 56